Pipeline Program (unspecified)
Alzheimer's Disease / Dementia
Key Facts
About Neurim Pharmaceuticals
Neurim Pharmaceuticals is a private, commercial-stage biotech company with a long-standing focus on CNS disorders, particularly those related to sleep and circadian rhythms. Founded by neuroscientist Nava Zisapel and entrepreneur Yehuda Zisapel, the company has built a commercial footprint with its approved drugs Circadin and Slenyto, which are marketed in over 40 countries. Neurim is leveraging its expertise to expand into adjacent therapeutic areas like Alzheimer's dementia and sleep apnea through internal R&D and strategic partnerships. The company operates with a hybrid business model of direct commercialization and out-licensing.
View full company profileAbout Neurim Pharmaceuticals
Neurim Pharmaceuticals is a private, commercial-stage biotech company with a long-standing focus on CNS disorders, particularly those related to sleep and circadian rhythms. Founded by neuroscientist Nava Zisapel and entrepreneur Yehuda Zisapel, the company has built a commercial footprint with its approved drugs Circadin and Slenyto, which are marketed in over 40 countries. Neurim is leveraging its expertise to expand into adjacent therapeutic areas like Alzheimer's dementia and sleep apnea through internal R&D and strategic partnerships. The company operates with a hybrid business model of direct commercialization and out-licensing.
View full company profile